Getting to the Heart of Norms for Elite Female Athletes
A study from NewYork-Presbyterian and Columbia University provides valuable information on how the heart adapts to intense physical training by WNBA players.
The first-ever cardiac study of elite female basketball players in the United States shows how their hearts adapt to intense physical training, finding that their hearts are generally larger and more muscular than the hearts of non-athletes.
The study of 140 WNBA players by researchers at NewYork-Presbyterian and Columbia University Irving Medical Center also provides physicians with a frame of reference when screening for cardiac problems in female athletes.
Why Study WNBA Players?
Intense physical exercise increases the size, mass, and thickness of the walls of the heart.
“We call this ‘athlete’s heart,’ and we’ve recognized this remodeling process for decades,” says Dr. David J. Engel, a sports cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center and senior author of the paper. “But nearly all published data on this describes athletic changes in the hearts of male athletes, and there is very little data on what an athletic heart looks like in elite female athletes, and absolutely no data on the athletic heart in women who are professional basketball players.”
Team physicians and physicians who care for athletes need to know what a healthy heart in elite athletes looks like so that healthy hearts can be distinguished from those with signs of cardiac problems, including hypertrophic cardiomyopathy, an enlargement and thickening of the heart that can lead to life-threatening arrhythmias.
The research is the result of a long-standing collaboration among cardiologists and researchers at NewYork-Presbyterian and Columbia University Irving Medical Center, the National Basketball Association and the Women’s National Basketball Association, and the National Basketball and Women’s National Basketball Players Associations that has also created a screening and monitoring program for the leagues and guidelines for NBA and WNBA team physicians. The research team has previously reported similar data on male NBA players.
The new research, published in JAMA Cardiology, also suggests that similar studies of female athletes are needed for other sports, which affect the heart in different ways.
Among U.S. athletes, basketball players have been shown in epidemiologic studies to have the highest incidence of exercise-induced sudden cardiac death, though the incidence is lower for female athletes than for males.
In 2006, the NBA was the first professional sports league to implement a standardized preseason screening program that tests all its players for heart disease.
“But without normative data on how training for professional basketball affects heart structure compared with non-athletes or athletes from other sports, it isn’t easy to identify who is at risk,” says Dr. Sofia Shames, a cardiologist at NewYork-Presbyterian/Columbia University Irving Medical Center and the study’s lead author.
“Evaluating the WNBA players on a large scale allows us to have comparison data for the future. Up until this research, some players were being sidelined until further tests could be done,” says Dr. Marci Goolsby, the team physician for the WNBA New York Liberty, a sports medicine physician at the Women’s Sports Medicine Center of the Hospital for Special Surgery, and a co-author of the paper. “We now have a much clearer picture of how to interpret data from preseason echocardiograms, and we can better determine who requires further testing.”
Basketball Strengthens Heart
In the study, the researchers analyzed cardiac ultrasound data from the 2017 season in 140 WNBA athletes, all of whom had similar training.
The researchers found that the WNBA players generally have larger and thicker (more muscular) hearts than most women who are not athletes, and the differences can be attributed to a combination of the larger height of WNBA players and their physical conditioning.
According to heart disease screening guidelines, which are based on data from the general population, approximately 16% of the WNBA players could be inappropriately classified as having left ventricular enlargement.
“The general population is not particularly athletic, and a physician who sees a heart the size of many WNBA players’ hearts would do further testing,” Dr. Shames says. “But in this group of women, these larger hearts are within the normal range for the athletes’ size and conditioning.”
The hearts of the WNBA players had also strengthened in different ways than the hearts of other female athletes. More than half the WNBA players had heart walls greater than 1 centimeter in thickness, compared with less than 10% of Italian female athletes from a variety of sports. The scans also showed that an important index of heart geometry — the thickness of the heart muscle in relation to diameter — was more prominent in the WNBA players compared with other female athletes.
“That’s why we need reference data for players in each specific sport,” Dr. Engel adds. “If WNBA team physicians relied on the data from the European studies to screen players for heart disease, they would still be left with clinical questions. Our research can hopefully serve as a stimulus for more studies of female athletes in other sports.”
A version of this story first appeared on Columbia University Irving Medical Center’s newsroom.
The study is titled “Echocardiographic Characterization of Female Professional Basketball Players in the U.S.”
Additional authors are Dr. Natalie A. Bello, Dr. Allan Schwartz, Dr. Shunichi Homma, and Nidhi Patel, all from NewYork-Presbyterian/Columbia University Irving Medical Center; Dr. Juan Garza, of the Heart and Vascular Institute of Texas in San Antonio; Dr. Jonathan H. Kim, of Emory University School of Medicine in Atlanta; and Dr. John P. DiFiori, of the Hospital for Special Surgery in New York City, and director of sports medicine for the NBA.
The study was supported by funding from the WNBA as part of a medical services agreement between the WNBA and Columbia University Irving Medical Center.